OTCPK:CMOPF (Ireland)
Â
Registered Shares
$
95.00
0 (0%)
10:08 PM EST
New Key Statistics Module, Z-Score and F-Score
OTCPK:CMOPF Key Ratios
| Market Cap $ M | 1,466.63 |
| Enterprise Value $ M | 1,319.37 |
| P/E(ttm) | 19.03 |
| PE Ratio without NRI | 19.18 |
| Forward PE Ratio | 14.60 |
| Price/Book | 2.64 |
| Price/Sales | 7.18 |
| Price/Free Cash Flow | 13.57 |
| Price/Owner Earnings | -- |
| Payout Ratio % | 0.25 |
| Revenue (TTM) $ M | 200.00 |
| EPS (TTM) $ | 4.63 |
| Beneish M-Score | -2.89 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 146.00 |
| EV-to-EBIT | 13.12 |
| EV-to-EBITDA | 11.31 |
| PEG | -- |
| Shares Outstanding M | 16.05 |
| Net Margin (%) | 37.80 |
| Operating Margin % | 47.18 |
| Pre-tax Margin (%) | 46.99 |
| Quick Ratio | 4.48 |
| Current Ratio | 4.85 |
| ROA % (ttm) | 10.84 |
| ROE % (ttm) | 15.49 |
| ROIC % (ttm) | 13.16 |
| Dividend Yield % | 2.29 |
| Altman Z-Score | 7.44 |
CMOPF Number of Guru Trades
CMOPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CMOPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CMOPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cosmo Pharmaceuticals NV Insider Transactions
No Available Data
News about OTCPK:CMOPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers